Our findings showing that AA carriers remained independently associated with risk for all and for high-grade prostate cancer, suggest that this SNP may modulate IGF1R cell surface protein quantity, as well as IGF1R/IGF1R internalization and degradation, consequently influencing prostate tumor growth. This evidence concerns the gene IGF1R and Familial prostate cancer.